Clavulanate Potassium

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

41 API Suppliers, 25 USDMF, 34 CEP/COS, 61 KDMF, 12 NDC API, 9 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Formulations

530 Dossiers, 73 FDA Orange Book, 221 Europe, 14 Australia, 99 South Africa, 123 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 125MG/5ML;EQ 31.25MG BASE/5ML, FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML, TABLET;ORAL - 875MG;EQ 125MG BASE, FOR SUSPENSION;ORAL - 200MG/5ML;EQ 28.5MG BASE/5ML, FOR SUSPENSION;ORAL - 400MG/5ML;EQ 57MG BASE/5ML, FOR SUSPENSION;ORAL - 600MG/5ML;EQ 42.9MG BASE/5ML, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 62.5MG BASE

TABLET;ORAL - 250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 125MG/5ML;EQ 31.25MG BASE/5ML
FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML
TABLET;ORAL - 875MG;EQ 125MG BASE
FOR SUSPENSION;ORAL - 200MG/5ML;EQ 28.5MG BASE/5ML
FOR SUSPENSION;ORAL - 400MG/5ML;EQ 57MG BASE/5ML
FOR SUSPENSION;ORAL - 600MG/5ML;EQ 42.9MG BASE/5ML
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 62.5MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 31 BASF, 17 Kerry, 16 Microlex e.U, 16 Roquette, 13 SPI Pharma, 12 Seppic, 11 Gangwal Chemicals, 11 Corel Pharma Chem, 11 Sigachi Industries, 9 Gangwal Healthcare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Nanjing Well Pharmaceutical, 6 Actylis, 6 Lonza Capsugel, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Ideal Cures Pvt Ltd, 5 Kima Chemical, 5 Rochem International Inc, 5 Boai NKY Pharmaceuticals Ltd, 4 Vasa Pharmachem, 4 Pharmatrans-Sanaq, 4 The Dow Chemical Company, 4 Prachin Chemical, 4 DFE Pharma, 3 Ingredion Pharma Solutions, 3 DKSH, 2 Seqens, 2 Finar, 2 Ulanqab Kema New Material, 2 Jai Radhe Sales, 2 Nomisma Healthcare, 2 Clariant, 1 Evonik, 1 Vertellus, 1 Pfanstiehl, 1 Nanjing Bold Chemical, 1 ACG Worldwide, 1 Qualicaps, 1 Avesta Pharma, 1 Aeon Procare, 1 Pharm-RX Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

57 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 41 Disintegrants & Superdisintegrants, 34 Direct Compression, 32 Controlled & Modified Release, 30 Thickeners and Stabilizers, 29 Solubilizers, 26 Granulation, 20 Topical, 20 Film Formers & Plasticizers, 20 Taste Masking, 17 Parenteral, 17 Lubricants & Glidants, 15 Chewable & Orodispersible Aids, 11 Co-Processed Excipients, 7 Emulsifying Agents, 7 Rheology Modifiers, 7 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents